Atkinson Edward Morrow III sold VRTX
February 17, 2026 · Form 4 insider transaction
Atkinson Edward Morrow III sold 2,031 shares of Vertex Pharmaceuticals Incorporated at $489.46 per share, a transaction worth $994.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,031
Price
$489.46
Total value
$994.1K
InsiderAtkinson Edward Morrow III
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after21,544
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.